{"schema_version":"secwatch.filing_event.v1","accession":"0000950142-23-001374","form_type":"8-K","ticker":"EXEL","cik":"0000939767","company_name":"EXELIXIS, INC.","filed_at":"2023-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.942499+00:00","generated_at":"2026-06-15T15:27:17.973868+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Exelixis director Lance Willsey resigns; Board adds Farallon nominee, ends proxy fight","bullets":["Lance Willsey, M.D. resigned from Exelixis board effective May 7, 2023; resignation relates to personal matter from over a decade ago.","Board will not contest Farallon's additional nominee David Johnson at May 31, 2023 Annual Meeting; recommends voting for its 10 remaining nominees.","Board previously nominated two Farallon candidates (Tomas Heyman, Robert Oliver) to replace two existing directors.","Board commits to replacing two additional directors over next two years (one per year) with new independent directors.","Over three years, five directors will have transitioned off, four new independent directors elected, including all Farallon nominees."],"urls":{"canonical":"https://secwatch.observer/filing/0000950142-23-001374","json":"https://secwatch.observer/filing/0000950142-23-001374.json","markdown":"https://secwatch.observer/filing/0000950142-23-001374.md","text":"https://secwatch.observer/filing/0000950142-23-001374.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/939767/000095014223001374/0000950142-23-001374-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/939767/000095014223001374/eh230356795_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T15:27:17.973868+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ed3f1898a8","claim":"Lance Willsey resigned as Director at EXELIXIS, INC..","evidence_excerpt":"On May 7, 2023, the Board of Directors (the “Board”) of Exelixis, Inc. (the “Company”) announced that Dr. Lance Willsey was resigning from the Board effective immediately","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/939767/000095014223001374/0000950142-23-001374-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}